230 related articles for article (PubMed ID: 32642255)
1. Noninvasive biomarkers for lung cancer diagnosis, where do we stand?
Kammer MN; Massion PP
J Thorac Dis; 2020 Jun; 12(6):3317-3330. PubMed ID: 32642255
[TBL] [Abstract][Full Text] [Related]
2. Risk stratification of indeterminate pulmonary nodules.
Paez R; Kammer MN; Massion P
Curr Opin Pulm Med; 2021 Jul; 27(4):240-248. PubMed ID: 33973553
[TBL] [Abstract][Full Text] [Related]
3. A Classifier for Improving Early Lung Cancer Diagnosis Incorporating Artificial Intelligence and Liquid Biopsy.
Ye M; Tong L; Zheng X; Wang H; Zhou H; Zhu X; Zhou C; Zhao P; Wang Y; Wang Q; Bai L; Cai Z; Kong FS; Wang Y; Li Y; Feng M; Ye X; Yang D; Liu Z; Zhang Q; Wang Z; Han S; Sun L; Zhao N; Yu Z; Zhang J; Zhang X; Katz RL; Sun J; Bai C
Front Oncol; 2022; 12():853801. PubMed ID: 35311112
[TBL] [Abstract][Full Text] [Related]
4. Preoperative diagnosis of malignant pulmonary nodules in lung cancer screening with a radiomics nomogram.
Liu A; Wang Z; Yang Y; Wang J; Dai X; Wang L; Lu Y; Xue F
Cancer Commun (Lond); 2020 Jan; 40(1):16-24. PubMed ID: 32125097
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of circulating genetically abnormal cells to support computed tomography for benign and malignant pulmonary nodules.
Yang H; Chen H; Zhang G; Li H; Ni R; Yu Y; Zhang Y; Wu Y; Liu H
BMC Cancer; 2022 Apr; 22(1):382. PubMed ID: 35397524
[TBL] [Abstract][Full Text] [Related]
6. 68Ga-DOTATATE PET/CT imaging of indeterminate pulmonary nodules and lung cancer.
Walker R; Deppen S; Smith G; Shi C; Lehman J; Clanton J; Moore B; Burns R; Grogan EL; Massion PP
PLoS One; 2017; 12(2):e0171301. PubMed ID: 28182730
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules.
Daly S; Rinewalt D; Fhied C; Basu S; Mahon B; Liptay MJ; Hong E; Chmielewski G; Yoder MA; Shah PN; Edell ES; Maldonado F; Bungum AO; Borgia JA
J Thorac Oncol; 2013 Jan; 8(1):31-6. PubMed ID: 23201823
[TBL] [Abstract][Full Text] [Related]
8. A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules.
Xing W; Sun H; Yan C; Zhao C; Wang D; Li M; Ma J
BMC Cancer; 2021 Mar; 21(1):263. PubMed ID: 33691657
[TBL] [Abstract][Full Text] [Related]
9. Role of baseline nodule density and changes in density and nodule features in the discrimination between benign and malignant solid indeterminate pulmonary nodules.
Xu DM; van Klaveren RJ; de Bock GH; Leusveld AL; Dorrius MD; Zhao Y; Wang Y; de Koning HJ; Scholten ET; Verschakelen J; Prokop M; Oudkerk M
Eur J Radiol; 2009 Jun; 70(3):492-8. PubMed ID: 18417311
[TBL] [Abstract][Full Text] [Related]
10. Identification and evaluation of circulating small extracellular vesicle microRNAs as diagnostic biomarkers for patients with indeterminate pulmonary nodules.
Zheng D; Zhu Y; Zhang J; Zhang W; Wang H; Chen H; Wu C; Ni J; Xu X; Nian B; Chen S; Wang B; Li X; Zhang Y; Zhang J; Zhong W; Xiong L; Li F; Zhang D; Xu J; Jiang G
J Nanobiotechnology; 2022 Apr; 20(1):172. PubMed ID: 35366907
[TBL] [Abstract][Full Text] [Related]
11. Role of biomarkers in lung nodule evaluation.
Sethi S; Cicenia J
Curr Opin Pulm Med; 2022 Jul; 28(4):275-281. PubMed ID: 35749790
[TBL] [Abstract][Full Text] [Related]
12. Management of incidental pulmonary nodules: current strategies and future perspectives.
Kim TJ; Kim CH; Lee HY; Chung MJ; Shin SH; Lee KJ; Lee KS
Expert Rev Respir Med; 2020 Feb; 14(2):173-194. PubMed ID: 31762330
[No Abstract] [Full Text] [Related]
13. Indeterminate Pulmonary Nodules: How to Minimize Harm.
Barjaktarevic I; Arenberg D; Grimes BS; Ruchalski K; Aberle DR
Semin Respir Crit Care Med; 2016 Oct; 37(5):689-707. PubMed ID: 27732991
[TBL] [Abstract][Full Text] [Related]
14. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.
Dewan NA; Gupta NC; Redepenning LS; Phalen JJ; Frick MP
Chest; 1993 Oct; 104(4):997-1002. PubMed ID: 8404239
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
[TBL] [Abstract][Full Text] [Related]
17. [Clinical Study of Artificial Intelligence-assisted Diagnosis System in Predicting the
Invasive Subtypes of Early-stage Lung Adenocarcinoma Appearing as Pulmonary Nodules].
Su Z; Mao W; Li B; Zheng Z; Yang B; Ren M; Song T; Feng H; Meng Y
Zhongguo Fei Ai Za Zhi; 2022 Apr; 25(4):245-252. PubMed ID: 35477188
[TBL] [Abstract][Full Text] [Related]
18. Screening for early stage lung cancer and its correlation with lung nodule detection.
Qian F; Yang W; Chen Q; Zhang X; Han B
J Thorac Dis; 2018 Apr; 10(Suppl 7):S846-S859. PubMed ID: 29780631
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules.
Veronesi G; Bellomi M; Mulshine JL; Pelosi G; Scanagatta P; Paganelli G; Maisonneuve P; Preda L; Leo F; Bertolotti R; Solli P; Spaggiari L
Lung Cancer; 2008 Sep; 61(3):340-9. PubMed ID: 18308420
[TBL] [Abstract][Full Text] [Related]
20. Indeterminate pulmonary nodules in colorectal cancer.
Jung EJ; Kim SR; Ryu CG; Paik JH; Yi JG; Hwang DY
World J Gastroenterol; 2015 Mar; 21(10):2967-72. PubMed ID: 25780294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
